Development of Sanofi Pasteur tetravalent dengue vaccine

by Jean Lang
Published 2012-10-01

Inköpsfunktionens interna strategiska betydelse : En fallstudie av Sanofi-Aventis inköpsfunktion

by Wickberg, Mattias, Söderström, Robert
Published 2005

Refined efficacy estimates of the Sanofi Pasteur dengue vaccine CYD-TDV using machine learning

by I. Dorigatti, C. A. Donnelly, D. J. Laydon, R. Small, N. Jackson, L. Coudeville, N. M. Ferguson
Published 2018-09-01

Estudio de caso: la identidad corporativa tras la fusión de Sanofi-Aventis en Chile

by Cares Inostroza, Carolina
Published 2017

XVI Premio Grupo Sanofi-Aventis Academia Nacional de Medicina a la Investigación Médica1

by Zoilo Cuéllar-Montoya
Published 2006-03-01

Gestão do capital intelectual na indústria farmacêutica: um estudo de caso na Sanofi Aventis Brasil

by Lima, João Paulo Cavalcante
Published 2016

La fabrique du discours sur la RSE : analyse, enjeux et dynamique. Le cas de Sanofi-Aventis

by Wehbi Sleiman, Manal
Published 2016

Press-release. «Sanofi» makes a contribution in improving availability of treatment in women...

by - -
Published 2014-06-01

Análise retrospectiva do mercado de medicamentos após a fusão entre o laboratório Medley e o laboratório Sanofi

by Guioti, Cidley de Oliveira
Published 2015

Factors Relevant to Intellectual Capital Management from the perspective of the Resource Based View (RBV): A Study Based on the Perception of Managers of Sanofi Aventis Brazil

by Maria Thereza Pompa Antunes, João Paulo Cavalcante Lima
Published 2012-06-01

Gestión de la comunicación intercultural entre colaboradores locales y la Casa Matriz en empresas transnacionales: Casos Laboratorios Sanofi Aventis, Banco Scotiabank y Ajinomoto

by Rocha Gonzales, Ursula Elena
Published 2017

Estudo de biodisponibilidade comparativa de uma formulação teste (Lipless [ciprofibrato] - comprimido - 100 mg; Biolab Sanus Farmacêutica Ltda.) versus uma formulação referência (Oroxadin [ciprofibrato] comprimido - 100 mg; Sanofi-Aventis) em voluntários sadios de ambos os sexos

by Modolo, Fabiana Duarte Mendes e, 1973-
Published 2012

Causal Effect Relationship in Medical Cases. An Old Problem in a New Scenario. Commentary to CJEU Judgment (Second Chamber) of 21 June 2017, N.W. & Others V. Sanofi Pasteur MSD & Others, Case C-621/15...

by Agata Wnukiewicz-Kozłowska, Urszula Dorota Drozdowska
Published 2021-08-01

Evaluation of direct cost in case of insulin GLA-100rgine-100 switching to insulin GLA-100rgine-300 in diabetes mellitus in real clinical practice

by D. Yu. Belousov, O. I. Karpov
Published 2018-05-01

Teriflunomide attenuates immunopathological changes in the Dark Agouti rat model of experimental autoimmune encephalomyelitis

by Garth E. Ringheim, Lan eLee, Lynn eLaws-Ricker, Thomas eDelohery, Li eLiu, Donghui eZhang, Nicholas eColletti, Timothy J Soos, Kendra eSchroeder, Barbara eFanelli, Nian eTian, Christopher W Arendt, Deborah eIglesias-Bregna, Margaret ePetty, Zhongqi eJi, George eQian, Rajula eGaur, Daniel eWeinstock, Jean eCavallo, Juventas eTelsinskas, Kathleen eMcMonagle-Strucko
Published 2013-10-01

Tetravalent Bispecific Tandem Antibodies Improve Brain Exposure and Efficacy in an Amyloid Transgenic Mouse Model

by Tuan-Minh Do, Cécile Capdevila, Laurent Pradier, Véronique Blanchard, Mati Lopez-Grancha, Nathalie Schussler, Anke Steinmetz, Jochen Beninga, Denis Boulay, Philippe Dugay, Patrick Verdier, Nadine Aubin, Gihad Dargazanli, Catarina Chaves, Elisabeth Genet, Yves Lossouarn, Christophe Loux, François Michoux, Nicolas Moindrot, Franck Chanut, Thierry Gury, Stéphanie Eyquem, Delphine Valente, Olivier Bergis, Ercole Rao, Dominique Lesuisse
Published 2020-12-01

An engineered IL-2 reprogrammed for anti-tumor therapy using a semi-synthetic organism

by Jerod L. Ptacin, Carolina E. Caffaro, Lina Ma, Kristine M. San Jose Gall, Hans R. Aerni, Nicole V. Acuff, Rob W. Herman, Yelena Pavlova, Michael J. Pena, David B. Chen, Lilia K. Koriazova, Laura K. Shawver, Ingrid B. Joseph, Marcos E. Milla
Published 2021-08-01

Pre-clinical development of a novel CD3-CD123 bispecific T-cell engager using cross-over dual-variable domain (CODV) format for acute myeloid leukemia (AML) treatment

by Hélène Bonnevaux, Stephane Guerif, Jana Albrecht, Erwan Jouannot, Thibaud De Gallier, Christian Beil, Christian Lange, Wulf Dirk Leuschner, Marion Schneider, Cendrine Lemoine, Anne Caron, Céline Amara, Cédric Barrière, Justine Siavellis, Valérie Bardet, Ernesto Luna, Pankaj Agrawal, Donald R. Drake, Ercole Rao, Peter Wonerow, Chantal Carrez, Véronique Blanc, Karl Hsu, Dmitri Wiederschain, Paula G. Fraenkel, Angéla Virone-Oddos
Published 2021-01-01

CRISPR/Cas9 generated knockout mice lacking phenylalanine hydroxylase protein as a novel preclinical model for human phenylketonuria

by Kuldeep Singh, Cathleen S. Cornell, Robert Jackson, Mostafa Kabiri, Michael Phipps, Mitul Desai, Robert Fogle, Xiaoyou Ying, Gulbenk Anarat-Cappillino, Sarah Geller, Jennifer Johnson, Errin Roberts, Katie Malley, Tim Devlin, Matthew DeRiso, Patricia Berthelette, Yao V. Zhang, Susan Ryan, Srinivas Rao, Beth L. Thurberg, Dinesh S. Bangari, Sirkka Kyostio-Moore
Published 2021-03-01

Pan-TGFβ inhibition by SAR439459 relieves immunosuppression and improves antitumor efficacy of PD-1 blockade

by Rita Greco, Hongjing Qu, Hui Qu, Joachim Theilhaber, Gary Shapiro, Richard Gregory, Christopher Winter, Natalia Malkova, Frank Sun, Julie Jaworski, Annie Best, Lily Pao, Andrew Hebert, Mikhail Levit, Alexei Protopopov, Jack Pollard, Keith Bahjat, Dmitri Wiederschain, Sharad Sharma
Published 2020-01-01